Payment overview · 2025
General Payments
$595.50
19 reported records · 12 companies
Healthcare provider profile · identity verified
Corey D Finch, MD
Allopathic & Osteopathic Physicians|Family Medicine · OKLAHOMA CITY, OK · NPI 1407903644
Verified facts
What the public records show
CMS Open Payments records show Corey D Finch, MD received $595.50 in general payments during 2025 across 19 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 32.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 11 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ingrezza, Rexulti, Xifaxan.
E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 2192 claims for Eliquis by this doctor in 2024.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Ingrezza by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 56 claims for Nuedexta by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 83 claims for Rexulti by this doctor in 2024.
Otsuka Pharmaceutical Development & Commercialization, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 1463 records involving 1088 distinct recipient NPIs. Public Medicare Part D data also shows 83 claims for Rexulti by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 2192 claims for Eliquis by this doctor in 2024.
Salix Pharmaceuticals, a division of Bausch Health US, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XIFAXAN as an associated drug or biological on 101901 records involving 33018 distinct recipient NPIs. Public Medicare Part D data also shows 59 claims for Xifaxan by this doctor in 2024.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO as an associated drug or biological on 28 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Austedo by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $195.71 | 32.9% | 7 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $136.24 | 22.9% | 1 | 2025 |
| Acarix USA Inc. | Unresolved — no canonical attribution shown | $43.99 | 7.4% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $39.13 | 6.6% | 2 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $34.32 | 5.8% | 1 | 2025 |
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $30.99 | 5.2% | 1 | 2025 |
| SK Life Science, Inc. |
SK Life Science, Inc. exact · evidence 2025-04-03 |
$23.64 | 4.0% | 1 | 2025 |
| UCB, Inc. | Unresolved — no canonical attribution shown | $21.81 | 3.7% | 1 | 2025 |
| E.R. Squibb & Sons, L.L.C. | Unresolved — no canonical attribution shown | $18.90 | 3.2% | 1 | 2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $18.38 | 3.1% | 1 | 2025 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | Unresolved — no canonical attribution shown | $16.31 | 2.7% | 1 | 2025 |
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $16.08 | 2.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $497.51 | 18 |
| Education | $97.99 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $136.24 | 1 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $97.72 | 6 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc., Otsuka Pharmaceutical Development & Commercialization, Inc. | $50.63 | 2 | 2025 |
Source payment records
|
|||||
| CADScor System Normalized: cadscor system |
Device | Acarix USA Inc. | $43.99 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $39.13 | 2 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $39.13 | 2 | 2025 |
Source payment records
|
|||||
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $30.99 | 1 | 2025 |
Source payment records
|
|||||
| Briviact Normalized: briviact |
Drug | UCB, Inc. | $21.81 | 1 | 2025 |
Source payment records
|
|||||
| COBENFY Normalized: cobenfy |
Drug | E.R. Squibb & Sons, L.L.C. | $18.90 | 1 | 2025 |
Source payment records
|
|||||
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.38 | 1 | 2025 |
Source payment records
|
|||||
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $16.08 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 18 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 83 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| XIFAXAN xifaxan |
2025 | Xifaxan | 2024 | 59 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
2192 | 273 |
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
56 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
83 | suppressed by CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 1463 supporting records · 1088 recipient NPIs · example record 1225319865 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
83 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
2192 | 273 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC Exact reporting entity; no affiliate inference |
2025 | XIFAXAN open payments reported associated product |
CMS Open Payments — General Payments 101901 supporting records · 33018 recipient NPIs · example record 1231775337 |
Xifaxan · 2024 Exact normalized brand match · 1 Part D row |
59 | suppressed by CMS |
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | AUSTEDO open payments reported associated product |
CMS Open Payments — General Payments 28 supporting records · 15 recipient NPIs · example record 1247249192 |
Austedo · 2024 Exact normalized brand match · 1 Part D row |
27 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2682 | 490 |
| Eliquis | Apixaban | 2192 | 273 |
| Levothyroxine Sodium | Levothyroxine Sodium | 2016 | 334 |
| Furosemide | Furosemide | 1915 | 357 |
| Potassium Chloride | Potassium Chloride | 1813 | 344 |
| Amlodipine Besylate | Amlodipine Besylate | 1693 | 321 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1583 | 303 |
| Gabapentin | Gabapentin | 1572 | 331 |
| Omeprazole | Omeprazole | 1399 | 242 |
| Lisinopril | Lisinopril | 1378 | 245 |
| Sertraline Hcl | Sertraline Hcl | 948 | 185 |
| Donepezil Hcl | Donepezil Hcl | 940 | 160 |
| Tamsulosin Hcl | Tamsulosin Hcl | 923 | 191 |
| Memantine Hcl | Memantine Hcl | 911 | 147 |
| Carvedilol | Carvedilol | 905 | 168 |
| Metoprolol Tartrate | Metoprolol Tartrate | 829 | 174 |
| Trazodone Hcl | Trazodone Hcl | 824 | 177 |
| Metformin Hcl | Metformin Hcl | 797 | 147 |
| Mirtazapine | Mirtazapine | 741 | 151 |
| Losartan Potassium | Losartan Potassium | 711 | 151 |
| Escitalopram Oxalate | Escitalopram Oxalate | 691 | 114 |
| Metoprolol Succinate | Metoprolol Succinate | 670 | 146 |
| Clopidogrel | Clopidogrel Bisulfate | 659 | 143 |
| Divalproex Sodium | Divalproex Sodium | 608 | 130 |
| Famotidine | Famotidine | 603 | 111 |
| Buspirone Hcl | Buspirone Hcl | 599 | 108 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 558 | 182 |
| Duloxetine Hcl | Duloxetine Hcl | 455 | 86 |
| Simvastatin | Simvastatin | 432 | 70 |
| Allopurinol | Allopurinol | 430 | 78 |
| Montelukast Sodium | Montelukast Sodium | 416 | 77 |
| Citalopram Hbr | Citalopram Hydrobromide | 399 | 79 |
| Levetiracetam | Levetiracetam | 399 | 78 |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 348 | 77 |
| Tramadol Hcl | Tramadol Hcl | 345 | 115 |
| Fluoxetine Hcl | Fluoxetine Hcl | 341 | 56 |
| Fluticasone Propionate | Fluticasone Propionate | 331 | 107 |
| Sucralfate | Sucralfate | 324 | 47 |
| Pravastatin Sodium | Pravastatin Sodium | 316 | 50 |
| Olanzapine | Olanzapine | 312 | 58 |
| Hydrochlorothiazide | Hydrochlorothiazide | 308 | 62 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 301 | 65 |
| Meloxicam | Meloxicam | 300 | 51 |
| Spironolactone | Spironolactone | 300 | 65 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 299 | 60 |
| Ondansetron Hcl | Ondansetron Hcl | 297 | 152 |
| Quetiapine Fumarate | Quetiapine Fumarate | 289 | 57 |
| Hydralazine Hcl | Hydralazine Hcl | 278 | 64 |
| Ropinirole Hcl | Ropinirole Hcl | 277 | 60 |
| Celecoxib | Celecoxib | 260 | 49 |
| Jardiance | Empagliflozin | 248 | 36 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 246 | 112 |
| Amiodarone Hcl | Amiodarone Hcl | 234 | 62 |
| Finasteride | Finasteride | 230 | 45 |
| Baclofen | Baclofen | 228 | 47 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 224 | 63 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 223 | 50 |
| Torsemide | Torsemide | 219 | 54 |
| Xarelto | Rivaroxaban | 215 | 28 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 214 | 43 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 209 | 101 |
| Myrbetriq | Mirabegron | 202 | 29 |
| Ozempic | Semaglutide | 200 | 31 |
| Trulicity | Dulaglutide | 197 | 31 |
| Risperidone | Risperidone | 190 | 37 |
| Oxybutynin Chloride | Oxybutynin Chloride | 189 | 40 |
| Januvia | Sitagliptin Phosphate | 188 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 188 | 47 |
| Trintellix | Vortioxetine Hydrobromide | 188 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 182 | 50 |
| Paroxetine Hcl | Paroxetine Hcl | 181 | 32 |
| Pregabalin | Pregabalin | 181 | 43 |
| Methenamine Hippurate | Methenamine Hippurate | 178 | 28 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 175 | 46 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 174 | 31 |
| Ezetimibe | Ezetimibe | 173 | 34 |
| Lorazepam | Lorazepam | 169 | 68 |
| Oxycodone Hcl | Oxycodone Hcl | 161 | 47 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 160 | 33 |
| Alendronate Sodium | Alendronate Sodium | 159 | 34 |
| Ondansetron Odt | Ondansetron | 159 | 80 |
| Lamotrigine | Lamotrigine | 158 | 26 |
| Midodrine Hcl | Midodrine Hcl | 158 | 36 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 157 | 40 |
| Prednisone | Prednisone | 157 | 68 |
| Novolog Flexpen | Insulin Aspart | 155 | 31 |
| Glipizide | Glipizide | 149 | 27 |
| Atenolol | Atenolol | 147 | 27 |
| Aripiprazole | Aripiprazole | 144 | 36 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 139 | 45 |
| Loperamide | Loperamide Hcl | 138 | 73 |
| Entresto | Sacubitril/Valsartan | 132 | 23 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 132 | 50 |
| Topiramate | Topiramate | 129 | 19 |
| Methocarbamol | Methocarbamol | 125 | 45 |
| Insulin Aspart Flexpen | Insulin Aspart | 123 | 34 |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 119 | 47 |
| Latanoprost | Latanoprost | 116 | 32 |
| Metformin Hcl Er | Metformin Hcl | 115 | 26 |
| Enulose | Lactulose | 111 | 38 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 111 | 23 |
| Clonidine Hcl | Clonidine Hcl | 107 | 41 |
| Bupropion Xl | Bupropion Hcl | 101 | 26 |
| Farxiga | Dapagliflozin Propanediol | 100 | 13 |
| Clonidine | Clonidine | 97 | 19 |
| Vraylar | Cariprazine Hcl | 96 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 95 | 31 |
| Sevelamer Carbonate | Sevelamer Carbonate | 91 | 18 |
| Metolazone | Metolazone | 90 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 89 | 22 |
| Gemtesa | Vibegron | 89 | 15 |
| Propranolol Hcl | Propranolol Hcl | 89 | 18 |
| Clozapine | Clozapine | 88 | suppressed |
| Dexamethasone | Dexamethasone | 88 | 50 |
| Digoxin | Digoxin | 88 | 17 |
| Amitriptyline Hcl | Amitriptyline Hcl | 85 | 21 |
| Fenofibrate | Fenofibrate Nanocrystallized | 85 | 17 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 85 | 20 |
| Nystatin | Nystatin | 85 | 44 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 84 | 23 |
| Clonazepam | Clonazepam | 83 | 17 |
| Rexulti | Brexpiprazole | 83 | suppressed |
| Glimepiride | Glimepiride | 82 | 18 |
| Nuplazid | Pimavanserin Tartrate | 80 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 79 | 19 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 78 | 78 |
| Bupropion Hcl Sr | Bupropion Hcl | 78 | 15 |
| Benztropine Mesylate | Benztropine Mesylate | 77 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 77 | 35 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 75 | 62 |
| Estradiol | Estradiol | 75 | 23 |
| Ibuprofen | Ibuprofen | 75 | 27 |
| Meclizine Hcl | Meclizine Hcl | 75 | 23 |
| Solifenacin Succinate | Solifenacin Succinate | 75 | 15 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 73 | 15 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 73 | 11 |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 71 | 17 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 70 | suppressed |
| Glipizide Er | Glipizide | 70 | 14 |
| Morphine Sulfate Er | Morphine Sulfate | 70 | 15 |
| Nifedipine Er | Nifedipine | 69 | 14 |
| Cephalexin | Cephalexin | 68 | 55 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 68 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 67 | 54 |
| Alprazolam | Alprazolam | 66 | 23 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 66 | 57 |
| Divalproex Sodium Er | Divalproex Sodium | 65 | 16 |
| Humalog | Insulin Lispro | 64 | 17 |
| Repaglinide | Repaglinide | 64 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 64 | 22 |
| Doxazosin Mesylate | Doxazosin Mesylate | 62 | 16 |
| Primidone | Primidone | 62 | 12 |
| Creon | Lipase/Protease/Amylase | 60 | suppressed |
| Nitroglycerin | Nitroglycerin | 60 | 46 |
| Oxcarbazepine | Oxcarbazepine | 60 | 11 |
| Bethanechol Chloride | Bethanechol Chloride | 59 | 12 |
| Xifaxan | Rifaximin | 59 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 58 | 13 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 57 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 56 | 32 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 56 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 56 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 55 | 18 |
| Lacosamide | Lacosamide | 54 | 12 |
| Movantik | Naloxegol Oxalate | 54 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 53 | suppressed |
| Multaq | Dronedarone Hcl | 53 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 53 | 47 |
| Prazosin Hcl | Prazosin Hcl | 53 | 11 |
| Spiriva Handihaler | Tiotropium Bromide | 53 | 12 |
| Azelastine Hcl | Azelastine Hcl | 52 | 11 |
| Bupropion Hcl | Bupropion Hcl | 52 | suppressed |
| Fenofibrate | Fenofibrate | 52 | suppressed |
| Methotrexate | Methotrexate Sodium | 52 | 12 |
| Metoclopramide Hcl | Metoclopramide Hcl | 52 | 13 |
| Ranolazine Er | Ranolazine | 52 | 15 |
| Pioglitazone Hcl | Pioglitazone Hcl | 49 | 11 |
| Hydrocortisone | Hydrocortisone | 48 | 24 |
| Levofloxacin | Levofloxacin | 48 | 40 |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 48 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 47 | 18 |
| Ramelteon | Ramelteon | 47 | suppressed |
| Tradjenta | Linagliptin | 47 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 46 | 11 |
| Incruse Ellipta | Umeclidinium Bromide | 46 | 11 |
| Irbesartan | Irbesartan | 46 | suppressed |
| Nystop | Nystatin | 46 | 33 |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 46 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 45 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 45 | 12 |
| Haloperidol Decanoate | Haloperidol Decanoate | 45 | suppressed |
| Timolol Maleate | Timolol Maleate | 45 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 45 | 12 |
| Folic Acid | Folic Acid | 44 | suppressed |
| Calcitriol | Calcitriol | 43 | suppressed |
| Azithromycin | Azithromycin | 42 | 38 |
| Novolog | Insulin Aspart | 42 | 14 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 42 | suppressed |
| Chlorthalidone | Chlorthalidone | 41 | suppressed |
| Oxycontin | Oxycodone Hcl | 41 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 41 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 40 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 40 | 19 |
| Linzess | Linaclotide | 40 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 39 | 13 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 39 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 38 | 12 |
| Megestrol Acetate | Megestrol Acetate | 38 | 18 |
| Phenobarbital | Phenobarbital | 38 | suppressed |
| Riluzole | Riluzole | 38 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 38 | 11 |
| Terazosin Hcl | Terazosin Hcl | 38 | suppressed |
| Lovastatin | Lovastatin | 37 | suppressed |
| Haloperidol | Haloperidol | 36 | suppressed |
| Budesonide Dr | Budesonide | 35 | suppressed |
| Cefdinir | Cefdinir | 35 | 33 |
| Imipramine Hcl | Imipramine Hcl | 35 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 35 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 35 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 35 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 34 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 34 | 30 |
| Insulin Degludec Pen (U-100) | Insulin Degludec | 34 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 33 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 33 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 33 | 12 |
| Levemir | Insulin Detemir | 33 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 33 | suppressed |
| Temazepam | Temazepam | 32 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 31 | 18 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 31 | suppressed |
| Ketoconazole | Ketoconazole | 31 | 12 |
| Amantadine | Amantadine Hcl | 30 | suppressed |
| Belsomra | Suvorexant | 30 | suppressed |
| Budesonide | Budesonide | 30 | 11 |
| Dapagliflozin | Dapagliflozin Propanediol | 30 | 16 |
| Mesalamine | Mesalamine | 30 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 30 | suppressed |
| Acetic Acid | Acetic Acid | 29 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 29 | 11 |
| Anastrozole | Anastrozole | 29 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 29 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 29 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 29 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 29 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 29 | 12 |
| Cefadroxil | Cefadroxil | 28 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 28 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 28 | suppressed |
| Sulfasalazine | Sulfasalazine | 28 | suppressed |
| Ubrelvy | Ubrogepant | 28 | suppressed |
| Vascepa | Icosapent Ethyl | 28 | suppressed |
| Austedo | Deutetrabenazine | 27 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 27 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 27 | 20 |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 27 | 22 |
| Lumigan | Bimatoprost | 27 | suppressed |
| Ursodiol | Ursodiol | 27 | suppressed |
| Admelog | Insulin Lispro | 26 | suppressed |
| Insulin Aspart | Insulin Aspart | 26 | 12 |
| Scopolamine | Scopolamine | 26 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 26 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 25 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 25 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 24 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 24 | suppressed |
| Fluconazole | Fluconazole | 24 | 17 |
| Metronidazole | Metronidazole | 24 | 13 |
| Naltrexone Hcl | Naltrexone Hcl | 24 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 24 | suppressed |
| Roflumilast | Roflumilast | 24 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 24 | suppressed |
| Verapamil Er | Verapamil Hcl | 24 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 23 | suppressed |
| Levemir Flexpen | Insulin Detemir | 23 | suppressed |
| Trimethoprim | Trimethoprim | 23 | suppressed |
| Valproic Acid | Valproic Acid | 23 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Epogen | Epoetin Alfa | 22 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 22 | suppressed |
| Letrozole | Letrozole | 22 | suppressed |
| Lidocaine | Lidocaine | 22 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 22 | 11 |
| Bumetanide | Bumetanide | 21 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 21 | suppressed |
| Levalbuterol Hcl | Levalbuterol Hcl | 21 | 11 |
| Moxifloxacin | Moxifloxacin Hcl | 21 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 20 | 13 |
| Calcium Acetate | Calcium Acetate | 20 | suppressed |
| Indapamide | Indapamide | 20 | suppressed |
| Insulin Lispro | Insulin Lispro | 20 | suppressed |
| Klayesta | Nystatin | 20 | suppressed |
| Mirabegron Er | Mirabegron | 20 | suppressed |
| Nyamyc | Nystatin | 20 | 15 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 20 | 20 |
| Prednisolone Acetate | Prednisolone Acetate | 20 | suppressed |
| Premarin | Estrogens, Conjugated | 20 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 19 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 19 | 15 |
| Diazepam | Diazepam | 19 | suppressed |
| Invokamet | Canagliflozin/Metformin Hcl | 19 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 19 | 19 |
| Sodium Chloride | Sodium Chloride Irrig Solution | 19 | suppressed |
| Brilinta | Ticagrelor | 18 | suppressed |
| Carbamazepine | Carbamazepine | 18 | suppressed |
| Cilostazol | Cilostazol | 18 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 18 | suppressed |
| Ingrezza | Valbenazine Tosylate | 18 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 18 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 18 | suppressed |
| Rivastigmine | Rivastigmine | 18 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 18 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 18 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 17 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 17 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 17 | suppressed |
| Humulin R | Insulin Regular, Human | 17 | suppressed |
| Mupirocin | Mupirocin | 17 | 14 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 17 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 17 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 16 | 12 |
| Arnuity Ellipta | Fluticasone Furoate | 16 | suppressed |
| Auryxia | Ferric Citrate | 16 | suppressed |
| Bevespi Aerosphere | Glycopyrrolate/Formoterol Fum | 16 | suppressed |
| Naproxen | Naproxen | 16 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Novolin R | Insulin Regular, Human | 16 | suppressed |
| Phenytoin | Phenytoin | 16 | suppressed |
| Amoxicillin | Amoxicillin | 15 | 14 |
| Colesevelam Hcl | Colesevelam Hcl | 15 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 15 | suppressed |
| Eszopiclone | Eszopiclone | 15 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Mesalamine Er | Mesalamine | 15 | suppressed |
| Olanzapine Odt | Olanzapine | 15 | suppressed |
| Pindolol | Pindolol | 15 | suppressed |
| Restasis | Cyclosporine | 15 | suppressed |
| Sotalol | Sotalol Hcl | 15 | suppressed |
| Telmisartan | Telmisartan | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Aristada | Aripiprazole Lauroxil | 14 | suppressed |
| Cimetidine | Cimetidine | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Formoterol Fumarate | Formoterol Fumarate | 14 | suppressed |
| Glucagon Emergency Kit | Glucagon | 14 | 11 |
| Halobetasol Propionate | Halobetasol Propionate | 14 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 14 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Carbamazepine Er | Carbamazepine | 13 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 13 | suppressed |
| Desipramine Hcl | Desipramine Hcl | 13 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Felodipine Er | Felodipine | 13 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 13 | suppressed |
| Modafinil | Modafinil | 13 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 13 | suppressed |
| Paliperidone Er | Paliperidone | 13 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 13 | 13 |
| Tadalafil | Tadalafil | 13 | suppressed |
| Verapamil Sr | Verapamil Hcl | 13 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 13 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Buprenorphine | Buprenorphine | 12 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 12 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Easy Touch Safety Pen Needle | Pen Needle, Diabetic, Safety | 12 | suppressed |
| Eplerenone | Eplerenone | 12 | suppressed |
| Insulin Degludec Pen (U-200) | Insulin Degludec | 12 | suppressed |
| Nifedipine | Nifedipine | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Thiothixene | Thiothixene | 12 | suppressed |
| Adlarity | Donepezil Hcl | 11 | suppressed |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 11 | suppressed |
| Ciprofloxacin-D5w | Ciprofloxacin In 5 % Dextrose | 11 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 11 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 11 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 11 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Methylprednisolone | Methylprednisolone | 11 | suppressed |
| Niacin Er | Niacin | 11 | suppressed |
| Qulipta | Atogepant | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 11 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 11 | suppressed |
| Victoza 3-Pak | Liraglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $595.50 · 19 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR, Briviact, CADScor System, COBENFY, FANAPT, INGREZZA, Korlym, NURTEC ODT, REXULTI, XIFAXAN, ZAVZPRET | 8 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ingrezza play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with E.R. Squibb & Sons, L.L.C.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error